COMMUNIQUÉS West-GlobeNewswire

Ligand to Host Investor Day on December 8, 2026
22/10/2026
JUPITER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place on Tuesday, December 8, 2026 from 10:30 a.m. to 12:00 p.m [...]
Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026
22/10/2026
BEDFORD, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2026 [...]
Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
22/10/2026
WATERTOWN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
22/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September [...]
Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026
22/10/2026
LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 27, 2026 at 8:30 a.m. Eastern [...]
A Race Against Blindness Celebrates Recent Fundraiser Winners During Blindness Awareness Month
22/10/2026
Nonprofit highlights winners and launches its popular Build Your Own Adventure Van fundraiser to advance research for childhood blindness GILBERT, Ariz., Oct. 22, 2026 (GLOBE NEWSWIRE) -- In recognition of October's [...]
Foundation for Sarcoidosis Research Welcomes Nine New Members to the FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA)
22/10/2026
The FSR-GSCA unites 55 leading clinics worldwide in a powerful, shared commitment to advancing research, transforming patient care, and accelerating progress toward a cure CHICAGO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- The [...]
Nordic Naturals Experts Share the Four Questions Every Consumer Should Ask About Their Supplements
22/10/2026
Not all supplements are created equal; No. 1 omega-3 brand‡ sets the bar for standards on purity, potency, freshness, and absorption Watsonville, CA, Oct. 22, 2026 (GLOBE NEWSWIRE) -- With the supplement market flooded [...]
IQity Draws Strong Surgeon Interest at First Exhibition Debut, AAO 2026
22/10/2026
Integrated workflow of IQ-Meter, IQ-SurgiView and IQ-Flow demonstrated live for the first time; surgeons single out robotic visualization, console-free ECP and a compact all-in-one diagnostic suited to office-based [...]
SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI
22/10/2026
New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group demonstrates statistically significant higher survival in the primary analysis at Day 60, Day 90, and at hospital [...]
Walden Biosciences Announces Positive Data from Diabetic Kidney Disease Cohorts in Ongoing Phase 2 Study of WAL0921
22/10/2026
Six of 12 evaluable participants receiving WAL0921 treatment experienced proteinuria (UACR) reduction greater than 20 percent; median 32.4 percent UACR reduction among responders Initial clinical results provide proof- [...]
InflaRx Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026
22/10/2026
Data from pre-clinical renal disease models demonstrate potential of izicopan for kidney protection Structural modeling provides new insight into izicopan’s differentiated molecular profile Jena, Germany, Oct. 22, 2026 [...]
Regulated information: Disclosure of a transparency notification from Aberdeen Group plc
22/10/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 22 October 2026 – 6 PM CET Disclosure of a transparency notification from Aberdeen Group plc Pursuant to the Belgian act of 2 May 2007 on the [...]
One04 Therapeutics presents positive interim Phase 1 data for CPV-104 in C3 glomerulopathy in ASN Kidney Week late-breaker
22/10/2026
Met predefined primary and secondary objectives for the interim analysis CPV-104 was generally well tolerated in healthy volunteers and patients with C3 glomerulopathy (C3G) Exploratory analyses in patients with C3G [...]
Guerbet : Chiffre d’affaires au 30 septembre 2026.
22/10/2026
Chiffre d’affaires au 30 septembre 2026 Une activité conforme aux anticipations du Groupe Chiffre d’affaires au 30 septembre 2026 de 573,8 M€, en repli de 1,3% à TCC 1 et périmètre comparable 2 ; hors Chine, une [...]
Guerbet : Revenue at 30 September 2026.
22/10/2026
Revenue at 30 September 2026 Business in line with Group expectations Revenue at 30 September 2026 of €573.8m, down 1.3% at CER 1 and like-for-like 2 ; excluding China, business grew by 1%, with a positive contribution [...]
Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors
22/10/2026
New plan strengthens Alignment’s Arizona portfolio available to nearly 1.1 million Medicare beneficiaries across Maricopa, Pima and Santa Cruz counties PHOENIX, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, [...]
Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine
22/10/2026
TRUTAKNA, the first and only FDA-approved BAFF and APRIL inhibitor, achieved statistical significance in all prespecified endpoints, including eGFR change from baseline and annualized slope, and risk reduction in [...]
SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026
22/10/2026
LONG BEACH, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced it will report third quarter 2026 [...]

Pages